1. Home
  2. EFC vs MNKD Comparison

EFC vs MNKD Comparison

Compare EFC & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFC

Ellington Financial Inc.

HOLD

Current Price

$12.81

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$5.73

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFC
MNKD
Founded
2007
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
2010
2004

Fundamental Metrics

Financial Performance
Metric
EFC
MNKD
Price
$12.81
$5.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
6
Target Price
$14.54
$10.08
AVG Volume (30 Days)
2.4M
4.2M
Earning Date
02-26-2026
02-25-2026
Dividend Yield
12.14%
N/A
EPS Growth
1.22
23.47
EPS
1.33
0.10
Revenue
$329,815,000.00
$313,787,000.00
Revenue This Year
N/A
$21.40
Revenue Next Year
$8.81
$25.03
P/E Ratio
$9.65
$59.05
Revenue Growth
13.84
17.43
52 Week Low
$11.12
$3.38
52 Week High
$14.40
$6.51

Technical Indicators

Market Signals
Indicator
EFC
MNKD
Relative Strength Index (RSI) 27.36 51.71
Support Level $13.12 $5.42
Resistance Level $13.50 $5.94
Average True Range (ATR) 0.23 0.27
MACD -0.09 0.01
Stochastic Oscillator 4.98 68.14

Price Performance

Historical Comparison
EFC
MNKD

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: